Written Question·Department of Health and Social Care·UIN 83371
Abiraterone: Finance
Tabled: 20 October 2025
Answered: 30 October 2025
Question
Mr Louie French
Conservative — Old Bexley and Sidcup
To ask the Secretary of State for Health and Social Care, when the Clinical Priorities Advisory Group next plans to consider funding for Abiraterone in a prioritsation round.
Answer
Dr Zubir AhmedNHS England considered abiraterone as an off-label treatment for hormone sensitive, non-metastatic prostate cancer through its clinical policy development process in 2024/25. Through this process, NHS England confirmed that there was sufficient supporting...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 83371) →